Search results for: 'medicin and acquisition deal of 2025'
- Did you mean
- medicin and acquisition deaf of 2017
- Related search terms
- Acquisition Terms and Agreements in Pharma
- acquisition texas and agreements in pharma
- deals+on+demand
- medicin+and+acquisition+deal+of+2020
- medicin+and+acquisition+deal+of+2015
-
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025April 2025$3,995.00
Track JV activity across pharma and biotech with real-world examples, financial terms, and partnering trends—includes access to contract documents where available.
Learn More -
Cardiovascular Collaboration and Licensing Deals 2016-2025April 2025$3,995.00
Cardiovascular Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025March 2025$4,995.00
The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
-
Discovery Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025March 2025$4,995.00
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to discovery-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2025March 2025$4,995.00
The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2025) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Genomic Collaboration and Licensing Deals 2018-2025May 2025$3,995.00
Genomics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2018 to 2025
Learn More -
Immunology Collaboration and Licensing Deals 2016-2025April 2025$3,995.00
Immunology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2025
Learn More -
Bioinformatics Collaboration and Licensing Deals 2019-2025May 2025$3,995.00
Bioinformatics Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More -
Antibody Collaboration and Licensing Deals 2019-2025May 2025$3,995.00
Antibody Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2019 to 2025
Learn More